Form 8-K - Current report:
SEC Accession No. 0001104659-24-117691
Filing Date
2024-11-13
Accepted
2024-11-13 16:10:37
Documents
16
Period of Report
2024-11-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2428324d1_8k.htm   iXBRL 8-K 32590
2 EXHIBIT 99.1 tm2428324d1_ex99-1.htm EX-99.1 60047
7 GRAPHIC tm2428324d1_ex99-1img001.jpg GRAPHIC 5080
  Complete submission text file 0001104659-24-117691.txt   335802

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA gpcr-20241113.xsd EX-101.SCH 3893
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE gpcr-20241113_def.xml EX-101.DEF 27150
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE gpcr-20241113_lab.xml EX-101.LAB 37087
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gpcr-20241113_pre.xml EX-101.PRE 25774
18 EXTRACTED XBRL INSTANCE DOCUMENT tm2428324d1_8k_htm.xml XML 6207
Mailing Address 611 GATEWAY BLVD SUITE 223 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD SUITE 223 SOUTH SAN FRANCISCO CA 94080 (628) 229-9277
Structure Therapeutics Inc. (Filer) CIK: 0001888886 (see all company filings)

EIN.: 981480821 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41608 | Film No.: 241454272
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)